You are here

Novel 3D high-content/throughput assay with mobile device-based data acquisition

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43ES024644-01
Agency Tracking Number: R43ES024644
Amount: $150,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIEHS
Solicitation Number: PA13-234
Timeline
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
6611 MORNINGSIDE DR
HOUSTON, TX 77030-1905
United States
DUNS: 827741336
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 GLAUCO SOUZA
 (713) 790-1833
 gsouza@n3dbio.com
Business Contact
 GLAUCO SOUXA
Phone: (713) 790-1833
Email: gsouza@n3dbio.com
Research Institution
 Stub
Abstract

DESCRIPTION (provided by applicant): Currently available models for toxicity screening are not always accurate predictors of toxicity in humans. Animal models are commonly used, but they are costly, time-consuming, and ethically challenging, they vary between species, and they do not accurately predict toxicity in humans. In vitro toxicity tests have been explored for years as cheaper alternatives or as initial screens before in vivo testing, but there are still issues regarding accuracy, primarily becausethey are cultured on two-dimensional (2D) surfaces, while native tissues exist in three-dimensional environments (3D). As a result, while ethical and cost motivations drive toxicity screening towards in vitro models, the limitations of current in viro assays in mimicking native tissue have prevented their widespread acceptance and use. This proposal puts forward a 3D model that is rapid, quantitative, and representative for high-throughput toxicity testing. Recently, research has gravitated towards in

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government